Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

ArcelorMittal Stock Heads Higher on Strong Quarter, Outlook

By William White, InvestorPlace Writer
ArcelorMittal (MT) stock was on the rise today following the release of its earnings report for the third quarter of 2017.

Deleterious Earnings Momentum Drop GlaxoSmithKline (GSK) to Sell

By Portfolio Grader
GlaxoSmithKline Plc (NYSE:GSK) is a $88.4 billion in market value constituent of the Pharmaceuticals GICS industry group where The current Portfolio Grader ranking for GSK puts it 77 among the 133 companies in this industry group, giving it a below-average spot. GSK is ranked in the third quartile of the sector with a ranking of 499 among the 785 companies in the sector and number 3,205 in the 5000 company Portfolio Grader company universe.

SegWit2x Is Dead, and Not a Moment Too Soon!

By Josh Enomoto, InvestorPlace Contributor
On the eve of the SegWit2x Bitcoin hard fork, its promoters cancelled the launch, which ultimately will prove to be the right decision.

NTT Docomo’s (DCM) High-Level Earnings Momentum Keep it a Buy

By Portfolio Grader
Portfolio Grader currently ranks NTT Docomo Inc (NYSE:DCM) a Buy. Using Louis Navellier's investing methodology, this analytical tool researches stocks by employing proprietary fundamental and quantitative analytical tools. This represents no change from the previous week and is the same ranking DCM has had from Portfolio Grader for the last month.

J C Penney Company Inc Stock Surges on Surprising Q3 Earnings

By William White, InvestorPlace Writer
JC Penney (JCP) stock was flying high on Friday following the release of a surprising earnings beat for the third quarter of 2107.

Eli Lilly (LLY) Industry Group Rank Limit Rating

By Portfolio Grader
With a $92.0 billion market value, Eli Lilly and Company (NYSE:LLY) ranks in the top decile in its industry group, Pharmaceuticals, and in the top decile of sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the ranking for LLY by Portfolio Grader places it 42 among the 133 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 268 among the 785 companies in the sector, and number 1,725 in the nearly 5,000 company Portfolio Grader universe.

This Is How Big 2017’s Singles Day Could Be for Alibaba Group Holding Ltd

By James Brumley, InvestorPlace Feature Writer
The top line Alibaba reports for this year's Singles Day will make headlines, but BABA stock holders may want to pay closer attention to this.

High-End Earnings Visibility Analytics Raise Ranking of Novo Nordisk A/S (NVO) to Strong Buy

By Portfolio Grader
With a $98.0 billion market value, Novo Nordisk A/S (NYSE:NVO) ranks in the top 10% of its industry group, Pharmaceuticals, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader score places it 2 among the 133 companies in this industry group, positioning it among the leaders; in the top decile of the sector with a ranking of 29 among the 785 companies in the sector, and number 206 in the nearly 5,000 company Portfolio Grader universe.

Rating for Bristol-Myers Squibb Co (BMY) Drops….. Wilting Earnings Visibility

By Portfolio Grader
The current recommendation of Hold for Bristol-Myers Squibb Co (NYSE:BMY) is the result of using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Sanofi (SNY) Shares a Buy on Earnings Momentum

By Portfolio Grader
Sanofi SA (NYSE:SNY) is a constituent of the 133 company Pharmaceuticals GICS industry group, which is part of the 785 company GICS Health Care sector. SNY's market value is $114.9 billion which falls in the top 10% of its industry group. Currently, the stock's Portfolio Grader ranking places it 29 among the 133 companies in this industry group, placing it among the leaders; in the top quartile of the sector with a ranking of 189 among the 785 companies in the sector, and number 1,216 in the nearly 5,000 company Portfolio Grader universe.

Sales Growth Analytics Drive BP (BP) to Strong Buy

By Portfolio Grader
BP Plc (NYSE:BP) is a $133.8 billion in market value component of the Oil Gas & Consumable Fuels GICS industry group where the stock's current Portfolio Grader score places it 14 among the 290 companies in this industry group, putting it in the top decile. BP is ranked among the sector leaders with a ranking of 15 among the 363 companies in the sector and number 376 in the 5000 company Portfolio Grader company universe.

Total’s (TOT) Upgraded to Strong Buy

By Portfolio Grader
Currently, Total SA (NYSE:TOT) has a Strong Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. The shares have been upgraded from a Buy to a Strong Buy in the last week.

Exceptional Measures for Earnings Growth Keep Royal Dutch Shell (RDS.A) a Strong Buy

By Portfolio Grader
The current recommendation of Strong Buy for Royal Dutch Shell Plc (NYSE:RDS.A) is derived using the methods of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 3 months.

Adverse Earnings Growth Make Merck & Co (MRK) a Sell

By Portfolio Grader
With a $152.9 billion market value, Merck & Co (NYSE:MRK) ranks in the top decile in its industry group, Pharmaceuticals, and in the top 10% of its sector group, Health Care, in market value. From the prospective of investment attractiveness, the stock's Portfolio Grader ranking currently places it 115 among the 133 companies in this industry group, a spot that is well below-average; squarely in the bottom quartile of the sector with a ranking of 674 among the 785 companies in the sector, and number 4,114 in the nearly 5,000 company Portfolio Grader universe.

BP Stock Is Topping Out and It Is Time to Take Your Profits

By Vince Martin, InvestorPlace Contributor
The BP stock price has gained 20% since August - but other stocks, and Brent itself, have done better. Energy bulls have better options.

High-Level Earnings Momentum Make DowDuPont (DWDP) a Buy

By Portfolio Grader
Portfolio Grader currently ranks DowDuPont Inc (NULL:DWDP) a Buy. With proprietary fundamental and quantitative metrics developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. This represents no change from the previous week and is the same ranking DWDP has had from Portfolio Grader for 2 months.

Industry Group Rank Limit Verizon (VZ) Rating

By Portfolio Grader
Verizon Communication Inc (NYSE:VZ) ranks in the top 10% of its industry group, Diversified Telecommunication Services, and in the top decile of sector group, Telecommunication Services, with a market value of $193.4 billion. From an investment attractiveness prospective, VZ is ranked in the third quartile of the sector with a ranking of 41 among the 66 companies in the sector; The current Portfolio Grader ranking for VZ puts it 25 among the 45 companies in this industry group, giving it a below-average spot and number 2,499 in the 5000 company Portfolio Grader company universe.

Solid Quant Score Metrics Drive Upgrade of Novartis AG (NVS) to Buy

By Portfolio Grader
Novartis AG (NYSE:NVS) is ranked as a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The shares have been upgraded from a Hold to a Buy in the last week.

Analytics for Earnings Visibility Make AT&T (T) a Sell

By Portfolio Grader
Portfolio Grader currently ranks AT&T Inc (NYSE:T) a Sell. Using Louis Navellier's investing approach, this analytical tool evaluates stocks with fundamental and quantitative metrics. This represents no change from the previous week and is the same ranking T has had from Portfolio Grader for the last month.
Load More Articles